Customized Chemotherapy Did Not Improve Survival in Early NSCLC ...Middle East

Medscape - News
Tailoring adjuvant chemotherapy based on the expression of two molecular markers did not confer a survival advantage in patients with completely resected stage 2-3 NSCLC in a phase 3 trial. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Customized Chemotherapy Did Not Improve Survival in Early NSCLC )

Apple Storegoogle play

Also on site :

Most viewed in News